Hospital Estadual Mario Covas

Santo André, São Paulo 09190-615

0 studies enrolling now · 6 studies all time

What they study most

Acute Respiratory Distress Syndrome, Ards, COVID, Cardiovascular Disease, Colitis, Ulcerative, Coronavirus, Coronavirus Infection, Covid-19, Crohn Disease, Sars-CoV2, Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome Coronavirus 2

Studies at this site

• A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 — Completed
• A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early